- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01851122
The Effect of the Amino Acid L-Theanine on Alertness and Vigilance
December 5, 2023 updated by: David Bauer, The University of Texas Health Science Center, Houston
The amino acid l-theanine (the active ingredient in green tea) is considered to have a calming effect without causing sleepiness.
This study evaluates whether l-theanine affects blood pressure, heart rate, alertness, and sense of well-being.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
26
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Sugar Land, Texas, United States, 77478
- Physicians at Sugar Creek
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- adult
- able to swallow capsule
Exclusion Criteria:
- none
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Placebo capsule
|
|
|
Experimental: L-theanine capsule
|
L-theanine 250mg capsule
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Alertness
Time Frame: 48 hrs
|
The average response time to identify a small rectangle shown on a computer screen.
|
48 hrs
|
|
Alertness
Time Frame: 48 hrs
|
Degree of subjective alertness, measured on a visual analog scale
|
48 hrs
|
|
Well-Being
Time Frame: 48 hrs
|
Sense of subjective well-being as measured on a visual analog scale
|
48 hrs
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2011
Primary Completion (Actual)
October 1, 2012
Study Completion (Actual)
October 1, 2012
Study Registration Dates
First Submitted
May 3, 2013
First Submitted That Met QC Criteria
May 7, 2013
First Posted (Estimated)
May 10, 2013
Study Record Updates
Last Update Posted (Estimated)
December 13, 2023
Last Update Submitted That Met QC Criteria
December 5, 2023
Last Verified
December 1, 2023
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- HSC-GEN-11-0299
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.